Andrew Sells today (Friday 26 July) welcomed efforts by the shooting community to safeguard and conserve hundreds of hectares of land for wildlife, when he spoke at the Game Fair. The Chair of Natural England said despite this work “more needs to be done to ensure there is a balance between shooting and conservation.”

He said:

Sustainably-managed shoots are safeguarding wildlife like curlews and lapwings, reducing flood risk and storing carbon.

Natural England will sign a second agreement with the British Association for Shooting and Conservation this weekend placing sustainable land management at the heart of BASC’s mission and recognising that 70 per cent of land managed by those affiliated to the shooting organisation are Special Sites of Scientific Interest (SSSI).

However, he sounded a note of caution arguing that not all shoots are doing enough to protect the environment from damage.

He said:

Too many shoots seem to have lost sight of the balance between shooting and conservation and the natural environment. Has the size of the day’s bag become the dominant consideration? Are some shoots damaging, rather than enhancing, our natural environment? If so, I hope we can work together to eliminate any such practices.

And the recent terrible wildfires near Manchester have shown moorland managers and keepers bravely joining forces with firefighters to limit environmental damage. I applaud their tireless efforts.

We are also seeing more estates coming into partnership agreements with NE, voluntarily finding ways to enhance environment. These deepening relationships will be vital in joining up prime wildlife sites and achieving goals of 25 Year Environment Plan.

Now in its third year, the Insolvency Service’s annual event ‘Insolvency Live!’ welcomed more than 90 delegates to the BEIS Conference Centre in Westminster on Monday 23 July.

Chief Executive Sarah Albon kicked off proceedings welcoming participants and she was followed by the Insolvency Service’s Chairman, Steve Allinson, who reflected on the past year in insolvency.

The Chairman revealed that it’s been a busy year for the Insolvency Service and insolvency has been prominent in the news over the past 12 months with the collapse of a number of high-profile businesses, as well as proceedings taken against several well-known directors.

However, Steve Allinson added that most cases don’t hit the headlines, demonstrating that insolvency affects a substantial number of organisations, employees, creditors and smaller businesses.

The Chairman then highlighted some of the key results from the Insolvency Service’s recently published Annual Report, including the number of Bankruptcy and Debt Relief Orders, successful enforcement outcomes and the millions of pounds returned to creditors.

Next on the agenda was Dr John Tribe of Liverpool University, a senior law lecturer with interests in insolvency law, bankruptcy history and equity and trusts. Dr Tribe’s engaging presentation looked at the use of Company Voluntary Arrangements (CVAs) on the high street, comparing 2018 to previous years.

Central to Dr Tribe’s argument was the idea that while there are low numbers of CVAs with regards to high street businesses, they should be considered as a viable option to help rescue businesses and save jobs.

Following Dr Tribe there were further presentations from the Insolvency Service’s Adjudicator office and Statistics team, as well as a panel discussion focusing on how the Insolvency Service handles complex investigations, with a specific look at Carillion.

Delegates were also given the opportunity to engage with various teams from the Insolvency Service at the Trade Fayre and after lunch people had the choice to attend two separate workshops, one looking at insolvency practitioner regulation and the other exploring whether people are choosing the right debt solutions.

The penultimate presentation was delivered by Sarah Albon, who in contrast to the Chairman, looked at the year ahead.

Sarah Albon spoke about the Insolvency Service’s core purpose of delivering economic confidence and said that over the coming year, we will continue to help build, improve and maintain business and investor confidence and drive responsible business practices to support the Government deliver an economy that works for everyone.

Supporting those in financial distress, tackling financial wrongdoing and maximising returns to creditors remains central to the Insolvency Service. In particular, we will be preparing for Brexit, ensuring the effective oversight of regulatory system for Insolvency Practitioners, centralising in-bound call handling and continue to handle high-profile cases.

The final act of the day was a Q&A session with the Insolvency Service’s Senior Management Team (SMT). Chaired by Steve Allinson, people had been invited beforehand to submit questions to be put to the SMT before the session was opened up to the floor. Questions ranged from will there be changes to forms as a result of Brexit, were there plans to introduce digital creditor applications and the levels of funding for the Insolvency Service’s services.

Commenting on the event, Steve Allinson said:

The past year was a successful one for the Insolvency Service but we should not rest on our laurels as there is still more work to do to ensure the UK has the best insolvency framework to support a strong economy.

I would like to thank everyone who attended and participated in what was a productive and engaging Insolvency Live!, while recognising all the hard work put in by my colleagues to bring this event together – congratulations.

The Home Secretary decided to reschedule these products after receiving advice from experts during the two-part review he commissioned on June 19. It means that senior clinicians will be able to prescribe the medicines to patients with an exceptional clinical need.

The Department for Health and Social Care (DHSC) and the Medicines and Health products Regulatory Agency (MHRA) will now develop a clear definition of what constitutes a cannabis-derived medicinal product so they can be rescheduled and prescribed. Only products meeting this definition will be rescheduled. Other forms of cannabis will be kept under strict controls and will not be available on prescription.

In the meantime, clinicians will still be able to apply to the independent expert panel on behalf of patients wishing to access these products. The Home Secretary also confirmed today that all licence fees for applications made to the panel will be waived, and no fees will be charged in respect of applications which have already been granted.

The government is clear that today’s announcement does not pave the way towards legalising cannabis for recreational use. The penalties for unauthorised supply and possession will remain unchanged.

Home Secretary Sajid Javid said:

Recent cases involving sick children made it clear to me that our position on cannabis-related medicinal products was not satisfactory.

That is why we launched a review and set up an expert panel to advise on licence applications in exceptional circumstances.

Following advice from two sets of independent advisers, I have taken the decision to reschedule cannabis-derived medicinal products – meaning they will be available on prescription.

This will help patients with an exceptional clinical need, but is in no way a first step to the legalisation of cannabis for recreational use.

In the first part of the review commissioned by the Home Secretary, the Chief Medical Advisor, Professor Dame Sally Davies, concluded that there is evidence that medicinal cannabis has therapeutic benefits.

The Advisory Council on the Misuse of Drugs (ACMD) carried out the second part of the review, considering the appropriate schedule for cannabis-derived medicinal products, based on the balance of harms and public health requirements.

The ACMD recommended that such products meeting a clear definition of what constitutes a cannabis-derived medicinal product should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001. It agreed that there is evidence of medicinal benefits from some of these products in certain circumstances and clinicians in the UK should therefore have the option to prescribe cannabis-derived medicinal products for their patients.

In line with the ACMD’s recommendations, DHSC and the Home Office will develop additional frameworks and clinical guidelines to ensure that cannabis-derived medicinal products can be prescribed safely to patients but cannot be traded illicitly.

Up to 50 practices in England will be selected to join the 73 currently testing a new approach to dental care.

The new system incentivises dentists to offer full oral health assessments and self-care plans on top of traditional treatments.

In the first year of piloting the new approach, dentists reported that:

• 90% of patients had reduced or maintained levels of tooth decay
• 80% of patients had reduced or maintained levels of gum disease
• 97% of patients said they were satisfied with the dental care they received

The recently published evaluation report from the first year of testing recommended that a further group of dental practices should be recruited into the programme.

The new practices are currently being selected and will join from October 2018 and January 2019.

The existing 73 practices are continuing to test the new approach, with a new remuneration system added which supports dentists carrying out preventative work.

The scheme could be rolled out nationally from April 2020 if it can be shown to benefit patients, the NHS and dental practice following a thorough evaluation.

Health Minister Steve Brine said:

The government has made great progress in improving the oral health of patients and tooth decay among children continues to decrease ‒ but there is more we can do.

Our new proposed NHS dental contract focuses on prevention and quality of care and will be thoroughly tested to ensure it is financially sustainable for the NHS, patients and dentists.

Chief Dental Officer Sarah Hurley said:

The announcement of up to 50 more prototype practices is an important step in developing the NHS dental service in this its 70th year.

I welcome it and hope that further refinement and testing with the profession will lead us to a model that enables dentists and their teams to play their full part in the delivery of integrated care and further improvement of oral and general health.

A total eclipse of the Moon will occur on Friday 27 July 2018. This lunar eclipse exhibits the longest duration of totality at 103.6 minutes in the 21st century. It will be visible in its entirety from the Indian Ocean region, westernmost China, India, the Middle East, central Asia, Turkey and the eastern half of Africa. Most of Australia, the Philippines, Indonesia, most of China, western Africa and most of Europe will see the total phase of the eclipse.

Some of the total phase of the eclipse is visible from the United Kingdom as the Moon rises during the umbral (the Moon’s dark inner shadow) part of the eclipse. The Moon will rise in a totally-eclipsed state and we will see about three quarters of the total phase of the eclipse.

The Moon will rise at different times across the United Kingdom. For example, the Moon rises at 20:42 BST in Dover and at 21:43 BST in Portree on the Isle of Skye. This should help identify the approximate times of Moon rise in the UK for Friday 27 July 2018. Also, specific moon rise times for your location can be calculated using our dynamical astronomical data service, Websurf 2.0 or using our beta Android app, Sky High.

Further details of the eclipse can be found on HMNAO’s Eclipses Online web pages